Ajax-Loading

Roche Holding AG - End Period Cash Flow

Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.

The item "End-Period-Cash-Flow" stands at 14.53 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 03/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 42.44 percent compared to the value the year prior.
The 1 year change in percent is 42.44.
The 3 year change in percent is -36.87.
The 5 year change in percent is -32.76.
The 10 year change in percent is 64.04.

The Serie's long term average value is 12.30 Billion Swiss Francs. It's latest available value, on 06/30/2025, is 18.13 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 06/30/2025, is +290.56%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 06/30/2025, is -38.70%.

End Period Cash Flow for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - End Period Cash Flow905,699,262,464.00
LogoJohnson & Johnson - End Period Cash Flow486,508,953,600.00
LogoAbbVie Inc - End Period Cash Flow399,570,305,024.00
LogoAstraZeneca PLC - End Period Cash Flow280,205,508,085.11
LogoNovartis AG - End Period Cash Flow255,096,620,580.91